title: Drug therapies in older adults (part 2).
abstract: In this, the second of two articles, we continue our evaluation of drug therapies in older adults. Having previously described the pharmacokinetic and pharmacodynamic consequences of physiological ageing, along with the challenge of appropriate prescribing, we proposed four key questions which should be considered when prescribing for this cohort of the population. Does this agent reflect the priorities of the patient? Are there alternatives - with greater efficacy, effectiveness or tolerability - that might be considered? Are the dose, frequency and formulation appropriate? How does this prescription relate to concurrent medication? We also highlighted the reliance on subgroup analysis to demonstrate the efficacy of drug therapies for older adults in osteoporosis and the underutilisation of appropriate treatments for patients with Alzheimer's disease as a result of flawed guidelines. Here we describe current drug therapies in systolic heart failure, noting the limited inclusion of older adults in key trials, while also reviewing the pharmacological treatment of orthostatic hypotension. In doing so, we advocate the intermittent use of midodrine as a first-line treatment for orthostasis in older adults, counter to the generic guidelines produced by various learned societies, but in keeping with the scant trial data available.
authors.affiliation: King's Health Partners, King's College Hospital, London, UK; o.mukhtar@nhs.net.
authors.forename: Omar
authors.initials: O
authors.lastname: Mukhtar
authors.affiliation: Department of Clinical Gerontology, King's Health Partners, King's College Hospital, London, UK.
authors.forename: Stephen Hd
authors.initials: SH
authors.lastname: Jackson
mesh_terms: D000367:Age Factors; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D005853:Geriatrics / Q000379:methods*; D054143:Heart Failure, Systolic / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D002317:Cardiovascular Agents
keywords: Pharmacology; elderly; left ventricular dysfunction; orthostatic hypotension; postural hypotension; systolic heart failure
references.citation: Lancet. 1999 Jan 2;353(9146):9-13
references.pmid: 10023943
references.citation: Eur Heart J. 1999 Mar;20(6):421-8
references.pmid: 10213345
references.citation: Lancet. 1999 Jun 12;353(9169):2001-7
references.pmid: 10376614
references.citation: N Engl J Med. 1999 Sep 2;341(10):709-17
references.pmid: 10471456
references.citation: Circulation. 1999 Dec 7;100(23):2312-8
references.pmid: 10587334
references.citation: J Cardiovasc Pharmacol. 1999 Dec;34(6):782-90
references.pmid: 10598120
references.citation: N Engl J Med. 2000 Jan 20;342(3):145-53
references.pmid: 10639539
references.citation: Clin Auton Res. 2000 Feb;10(1):35-42
references.pmid: 10750642
references.citation: Heart. 2000 May;83(5):596-602
references.pmid: 10768918
references.citation: Hawaii Med J. 2000 Feb;59(2):48-50
references.pmid: 10800251
references.citation: Diabetes. 1975 Apr;24(4):381-4
references.pmid: 1094320
references.citation: Dtsch Med Wochenschr. 1975 Sep 5;100(36):1790-2
references.pmid: 1098888
references.citation: Arch Intern Med. 2001 Jan 22;161(2):165-71
references.pmid: 11176729
references.citation: Expert Opin Pharmacother. 2000 May;1(4):835-40
references.pmid: 11249519
references.citation: N Engl J Med. 2001 May 31;344(22):1651-8
references.pmid: 11386263
references.citation: Br J Clin Pharmacol. 2001 Aug;52(2):159-64
references.pmid: 11488772
references.citation: N Engl J Med. 2001 Dec 6;345(23):1667-75
references.pmid: 11759645
references.citation: Circulation. 2002 Aug 20;106(8):920-6
references.pmid: 12186794
references.citation: N Engl J Med. 2003 Apr 3;348(14):1309-21
references.pmid: 12668699
references.citation: J Hypertens. 1992 Jul;10(7):607-13
references.pmid: 1321186
references.citation: Lancet. 2003 Sep 6;362(9386):767-71
references.pmid: 13678869
references.citation: Lancet. 2003 Sep 6;362(9386):772-6
references.pmid: 13678870
references.citation: N Engl J Med. 1992 Sep 3;327(10):685-91
references.pmid: 1463530
references.citation: Am J Hypertens. 2004 Feb;17(2):103-11
references.pmid: 14751650
references.citation: Basic Res Cardiol. 2004 Mar;99(2):76-82
references.pmid: 14963665
references.citation: J Intern Med. 1992 Aug;232(2):139-45
references.pmid: 1506810
references.citation: N Engl J Med. 2004 Aug 5;351(6):543-51
references.pmid: 15295047
references.citation: Drugs. 2004;64(16):1757-65
references.pmid: 15301560
references.citation: Hypertension. 2004 Dec;44(6):913-8
references.pmid: 15492133
references.citation: Circulation. 2004 Oct 26;110(17):2618-26
references.pmid: 15492298
references.citation: Eur Heart J. 2005 Feb;26(3):215-25
references.pmid: 15642700
references.citation: Am J Cardiol. 2005 Apr 1;95(7):896-8
references.pmid: 15781028
references.citation: Nephron Physiol. 2006;103(3):p149-56
references.pmid: 16582578
references.citation: Eur J Neurol. 2006 Sep;13(9):930-6
references.pmid: 16930356
references.citation: N Engl J Med. 2007 Sep 20;357(12):1229-37
references.pmid: 17881754
references.citation: Circulation. 1991 Jun;83(6):1849-65
references.pmid: 1828192
references.citation: Eur Heart J. 2008 Dec;29(24):3022-8
references.pmid: 18987098
references.citation: Am J Med. 2009 Jun;122(6):574-80
references.pmid: 19486719
references.citation: Eur Heart J. 2009 Nov;30(21):2631-71
references.pmid: 19713422
references.citation: N Engl J Med. 1991 Aug 1;325(5):293-302
references.pmid: 2057034
references.citation: Lancet. 2010 Sep 11;376(9744):875-85
references.pmid: 20801500
references.citation: Auton Neurosci. 2011 Apr 26;161(1-2):46-8
references.pmid: 21393070
references.citation: Expert Rev Cardiovasc Ther. 2012 Mar;10(3):387-95
references.pmid: 22390810
references.citation: Age Ageing. 2012 Sep;41(5):587-94
references.pmid: 22591985
references.citation: Am J Ther. 2013 May-Jun;20(3):279-91
references.pmid: 23656967
references.citation: Int J Clin Pract. 2013 Jul;67(7):633-46
references.pmid: 23758443
references.citation: Eur J Heart Fail. 2013 Nov;15(11):1296-303
references.pmid: 23803951
references.citation: Drugs. 2013 Aug;73(12):1267-79
references.pmid: 23857549
references.citation: Med J Aust. 2013 Sep 2;199(5):334-9
references.pmid: 23992190
references.citation: N Engl J Med. 2014 Sep 11;371(11):993-1004
references.pmid: 25176015
references.citation: N Engl J Med. 1979 Jul 12;301(2):68-73
references.pmid: 449947
references.citation: N Engl J Med. 1996 May 23;334(21):1349-55
references.pmid: 8614419
references.citation: J Am Geriatr Soc. 1996 Jul;44(7):809-14
references.pmid: 8675929
references.citation: Clin Sci (Lond). 1996 Sep;91(3):283-91
references.pmid: 8869410
references.citation: JAMA. 1997 Apr 23-30;277(16):1299-304
references.pmid: 9109468
references.citation: J Cardiovasc Pharmacol. 1998 Jan;31(1):116-25
references.pmid: 9456286
references.citation: Circulation. 1998 Nov 24;98(21):2290-5
references.pmid: 9826316